We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$34.3M
(-25%)
Cap. Flow
-$33.3M
Cap. Flow
% of AUM
-33.2%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
32
Reduced
107
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$5.08M |
| 2 |
UnitedHealth
UNH
|
+$4.05M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.82M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$2.52M |
| 5 |
AbbVie
ABBV
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rithm Capital
RITM
|
+$4.32M |
| 2 |
Harmony Biosciences
HRMY
|
+$3.88M |
| 3 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$3.12M |
| 4 |
EFC
Ellington Financial
EFC
|
+$2.6M |
| 5 |
MGIC Investment
MTG
|
+$2.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.58% |
| 2 | Real Estate | 7.4% |
| 3 | Industrials | 5.96% |
| 4 | Financials | 5.87% |
| 5 | Technology | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Diamondback Energy
FANG
$57.6B
| $74.7K | 0.07% |
456
-23
| -5% | -$4.05K |
|
177
Progressive
PGR
$124B
| $74K | 0.07% |
309
-54
| -15% | -$13.6K |
|
178
Charter Communications
CHTR
$14.7B
| $73K | 0.07% |
213
-12
| -5% | -$4.34K |
|
179
iShares MSCI Italy ETF
EWI
$911M
| $72.8K | 0.07% |
2,025
-823
| -29% | -$30.7K |
|
180
Comcast
CMCSA
$79.1B
| $71.7K | 0.07% |
1,910
-92
| -5% | -$3.82K |
|
181
Norwegian Cruise Line
NCLH
$8.89B
| $70.3K | 0.07% |
2,734
-480
| -15% | -$12.1K |
|
182
Reinsurance Group of America
RGA
$15.7B
| $68.8K | 0.07% |
322
-56
| -15% | -$12.2K |
|
183
Prudential Financial
PRU
$41.7B
| $68.2K | 0.07% |
575
-95
| -14% | -$11.7K |
|
184
iShares MSCI India ETF
INDA
$6.71B
| $67.3K | 0.07% |
1,279
-878
| -41% | -$48.3K |
|
185
Cardinal Health
CAH
$53.4B
| $66.7K | 0.07% |
564
-96
| -15% | -$11.2K |
|
186
Evolent Health
EVH
$475M
| $60.8K | 0.06% |
+5,404
| New | +$95K |
|
187
Duolingo
DUOL
$5.7B
| $53.8K | 0.05% |
166
-29
| -15% | -$9.23K |
|
188
Arista Networks
ANET
$219B
| $52.2K | 0.05% |
472
-84
| -15% | -$8.64K |
|
189
Broadcom
AVGO
$1.82T
| $51.2K | 0.05% |
221
-38
| -15% | -$7.03K |
|
190
iShares MSCI United Kingdom ETF
EWU
$4.04B
| $48.2K | 0.05% |
1,423
-1,525
| -52% | -$54.3K |
|
191
Warner Bros
WBD
$64.6B
| $48K | 0.05% |
4,540
-798
| -15% | -$7.42K |
|
192
DoorDash
DASH
$75.3B
| $46K | 0.05% |
274
-48
| -15% | -$7.88K |
|
193
Microbot Medical
MBOT
$115M
| $44.8K | 0.04% |
40,000
-60,000
| -60% | -$58.7K |
|
194
MGM Resorts International
MGM
$11.7B
| $44.7K | 0.04% |
1,291
-227
| -15% | -$8.58K |
|
195
Howmet Aerospace
HWM
$116B
| $42.3K | 0.04% |
387
-68
| -15% | -$7.45K |
|
196
GXO Logistics
GXO
$6.06B
| $39.5K | 0.04% |
908
-160
| -15% | -$8.81K |
|
197
Celanese
CE
$5.09B
| $39K | 0.04% |
563
-28
| -5% | -$2.69K |
|
198
iShares MSCI Spain ETF
EWP
$1.98B
| $37.6K | 0.04% |
1,211
-2,054
| -63% | -$68.1K |
|
199
HubSpot
HUBS
$10.5B
| $34.8K | 0.03% |
50
-9
| -15% | -$5.79K |
|
|
GREK
200
Global X MSCI Greece ETF
GREK
$288M
| $32.6K | 0.03% |
840
-2,132
| -72% | -$85.9K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, AlphaCentric Advisors held 294 positions worth $100M, down 25% from $135M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
AlphaCentric Advisors withdrew a net $33.3M in Q4 2024, closing 85 positions and reducing 107 holdings. Its most notable exit was Rithm Capital, an estimated $4.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 58% a quarter earlier, followed by Real Estate and Industrials.
Against the trend, AlphaCentric Advisors opened a new position in Eli Lilly worth $4.74M.
- AlphaCentric Advisors's largest Q4 2024 buy was Eli Lilly: 6,140 shares worth $4.74M.
- AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.03M increase.
- AlphaCentric Advisors's biggest Q4 2024 reduction was Neurocrine Biosciences, cutting an estimated $2.33M.
- AlphaCentric Advisors fully exited Rithm Capital in Q4 2024, selling an estimated $4.32M.
- AlphaCentric Advisors's ten largest holdings make up 26% of its $100M portfolio in Q4 2024.
- AlphaCentric Advisors opened 64 new positions and closed 85 in Q4 2024.
- AlphaCentric Advisors's portfolio value fell 25% quarter-over-quarter to $100M.
Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.